financetom
Business
financetom
/
Business
/
Lilly's weekly insulin succeeds in late-stage studies
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lilly's weekly insulin succeeds in late-stage studies
May 16, 2024 4:15 AM

May 16 (Reuters) - Eli Lilly ( LLY ) said on Thursday

that its once-weekly insulin efsitora met the main goals in two

late-stage trials evaluating it in people with type 2 diabetes.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chinese manufacturing weakens as country battles COVID-19 surge
Chinese manufacturing weakens as country battles COVID-19 surge
Dec 31, 2022
The weakening of Chinese manufacturing comes as China earlier this month abruptly relaxed COVID-19 restrictions after years of attempts to stamp out the virus. The country of 1.4 billion is now facing a nationwide outbreak and authorities have stopped publishing a daily tally of COVID-19 infections.
US State Department says visa processing expected to reach pre-pandemic levels in FY 2023
US State Department says visa processing expected to reach pre-pandemic levels in FY 2023
Nov 18, 2022
The US visa processing is rebounding faster than projected and is expected to reach prepandemic levels in Fiscal Year 2023, the State Department has said, addressing the growing concern over backlog of visa applications from countries like India.
Oil rises 2% on Russian supply worries; US storm impact in focus
Oil rises 2% on Russian supply worries; US storm impact in focus
Dec 23, 2022
Brent crude was up by $1.40, or 1.70 percent, to $82.38 a barrel at 1044 GMT, while US West Texas Intermediate (WTI) crude was at $78.98 a barrel, up $1.49, or nearly 2 percent higher. Both contracts were on track to post a second weekly gain.
Don't see any sides surrendering in Russia-Ukraine war, says Thomas Loren Friedman
Don't see any sides surrendering in Russia-Ukraine war, says Thomas Loren Friedman
Dec 8, 2022
Many of global economies are expected to slip into a recession in the next few months. While developing economies like India may not see a recession, growth will certainly take a beating and exports will come under pressure. How can we navigate this uncertain environment? What can businesses do and what will the future look like? CNBC-TV18’s Shereen Bhan spoke to Thomas Loren Friedman, Pulitzer Winning Journalist and Columnist at the New York Times, and Uday Kotak, former CII President and MD and CEO of Kotak Mahindra Bank who are very keen watchers of the world economy.
Copyright 2023-2026 - www.financetom.com All Rights Reserved